Brolucizumab in recalcitrant neovascular age-related macular degeneration–real-world data in Chinese population
Article in PLOS ONE (April 2024)
The most recent citing publications are shown below. View all 75 publications that cite this research output on Dimensions.
Article in PLOS ONE (April 2024)
Article in Russian Ophthalmological Journal (December 2023)
Article in Asia-Pacific Journal of Ophthalmology (March 2023)